首页> 外文OA文献 >The PTTG1-Binding Factor (PBF/PTTG1IP) regulates p53 activity in thyroid cells.
【2h】

The PTTG1-Binding Factor (PBF/PTTG1IP) regulates p53 activity in thyroid cells.

机译:pTTG1结合因子(pBF / pTTG1Ip)调节甲状腺细胞中的p53活性。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The PTTG1-Binding Factor (PBF/PTTG1IP) has an emerging repertoire of roles, especially in thyroid biology, and functions as a proto-oncogene. High PBF expression is independently associated with poor prognosis and lower disease-specific survival in human thyroid cancer. However, the precise role of PBF in thyroid tumorigenesis is unclear. Here, we present extensive evidence demonstrating that PBF is a novel regulator of p53, a tumor suppressor protein with a key role in maintaining genetic stability, which is infrequently mutated in differentiated thyroid cancer. By coimmunoprecipitation and proximity ligation assays, we show that PBF binds specifically to p53 in thyroid cells, and significantly represses transactivation of responsive promoters. Further, we identify that PBF decreases p53 stability by enhancing ubiquitination, which appears dependent on the E3 ligase activity of Mdm2. Impaired p53 function was evident in a transgenic mouse model with thyroid-specific PBF over-expression (PBF-Tg), which had significantly increased genetic instability as indicated by FISSR-PCR analysis. Consistent with this, ∼40% of all DNA repair genes examined were repressed in PBF-Tg primary cultures, including genes with critical roles in maintaining genomic integrity such as Mgmt, Rad51 and Xrcc3. Our data also revealed that PBF induction resulted in upregulation of the E2 enzyme Rad6 in murine thyrocytes, and was associated with Rad6 expression in human thyroid tumors. Overall, this work provides novel insights into the role of the proto-oncogene PBF as a negative regulator of p53 function in thyroid tumorigenesis, where PBF is generally over-expressed and p53 mutations are rare compared to other tumor types.
机译:PTTG1结合因子(PBF / PTTG1IP)具有新兴的功能,尤其是在甲状腺生物学中,并且起着原癌基因的作用。 PBF的高表达与人类甲状腺癌的不良预后和较低的疾病特异性生存率独立相关。然而,尚不清楚PBF在甲状腺肿瘤发生中的确切作用。在这里,我们提供了广泛的证据,证明PBF是p53的新型调节剂,p53是一种肿瘤抑制蛋白,在维持遗传稳定性中起关键作用,而在分化的甲状腺癌中这种突变很少发生。通过共免疫沉淀和邻近连接测定,我们显示PBF特异性结合甲状腺细胞中的p53,并显着抑制应答性启动子的反式激活。此外,我们发现PBF通过增强泛素化降低了p53的稳定性,泛素化似乎取决于Mdm2的E3连接酶活性。在具有甲状腺特异性PBF过表达(PBF-Tg)的转基因小鼠模型中,p53功能受损很明显,如FISSR-PCR分析所示,其基因不稳定性明显增加。与此相一致,在PBF-Tg原代培养物中,约40%的所有DNA修复基因被抑制,包括在维持基因组完整性方面具有关键作用的基因,例如Mgmt,Rad51和Xrcc3。我们的数据还显示,PBF诱导导致鼠甲状腺细胞中E2酶Rad6的上调,并且与人类甲状腺肿瘤中Rad6的表达有关。总体而言,这项工作为原癌基因PBF在甲状腺肿瘤发生中作为p53功能的负调节剂的作用提供了新颖的见解,其中PBF通常过度表达,与其他类型的肿瘤相比,p53突变很少见。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号